Salvage therapy with etoposide and mitoxantrone in patients with refractory acute myeloid leukemia: a retrospective cohort study
The EM regimen offers a potential pathway to remission for R/R non-M3 AML patients. However, the outcomes are heavily influenced by patient-specific factors and subsequent treatment strategies such as HSCT.
Authors
- Kamran Roudini (ORCID: https://orcid.org/0000-0003-0166-0505)
- Mehrzad Mirzania
- Ahmad Khajeh-Mehrizi (ORCID: https://orcid.org/0000-0002-4607-7842)
- Hamideh Rashidian (ORCID: https://orcid.org/0000-0002-2155-1683)
- Tahereh Yavari (ORCID: https://orcid.org/0000-0002-2855-5492)
- Khashayar Danandeh (ORCID: https://orcid.org/0000-0002-1361-6205)
- Seyed Reza Safaei Nodehi
- Peyman Tayyari
Institutions
- University of Tehran (IR)
- Imam Khomeini Hospital (IR)
- Shariati Hospital (IR)
- Tehran University of Medical Sciences (IR)
Publication Details
- Journal
- Annals of Medicine and Surgery
- Published
- 2025-11-13
- DOI
- https://doi.org/10.1097/ms9.0000000000004285
- Primary Topic
- Acute Myeloid Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00